Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 86
- Press Release
- Press Release PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Combination Trial in rGBM Patients Abstract at the 2020 ASCO Annual Meeting
- 관리자
- 6 Apr 2020
- Views334
- 0
- 85
- News Article
- News Article PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine's existing assets to non-oncology areas
- Manager
- 23 Mar 2020
- Views464
- 1
- 84
- News Article
- News Article PharmAbcine to Participate in BIO Digital Conference
- Manager
- 20 Mar 2020
- Views364
- 1
- 83
- News Article
- News Article PharmAbcine, AACR Annual Meeting 2020
- Manager
- 11 Feb 2020
- Views384
- 1
- 82
- News Article
- News Article PharmAbcine, invited speaker at KSMO 2020
- Manager
- 11 Feb 2020
- Views406
- 1
- 81
- News Article
- News Article PharmAbcine, to Participate in Both J.P. Morgan Health Conference 2020 and Biotech Showcase in San Francisco, Ca, USA
- Manager
- 8 Jan 2020
- Views553
- 1
- 80
- News Article
- News Article PharmAbcine, to Present in KABSP-SF 2020, San Francisco
- Manager
- 3 Jan 2020
- Views389
- 1
- 79
- PR Video
- PR Video PharmAbcine makes great strides in immune oncology cancer treatments with successful trials
- 관리자
- 28 Nov 2019
- Views377
- 0
- 78
- Press Release
- Press Release PharmAbcine, Olinvacimb, able to manage the first recruitment of patients for phase II clinical trial
- 관리자
- 20 Nov 2019
- Views376
- 0
- 77
- News Article
- News Article PharmAbcine, Korea-Europe Gathering for Open Innovation_KDHI
- Manager
- 25 Oct 2019
- Views377
- 1